The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000260.4(MYO7A):c.1997G>A (p.Arg666Gln)

CA6197659

556881 (ClinVar)

Gene: MYO7A
Condition: Usher syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: 4923dcaa-6018-41a1-b68f-39af89d9e3cf
Approved on: 2025-03-12
Published on: 2025-06-30

HGVS expressions

NM_000260.4:c.1997G>A
NM_000260.4(MYO7A):c.1997G>A
NM_000260.4(MYO7A):c.1997G>A (p.Arg666Gln)
NC_000011.10:g.77174817G>A
CM000673.2:g.77174817G>A
NC_000011.9:g.76885863G>A
CM000673.1:g.76885863G>A
NC_000011.8:g.76563511G>A
NG_009086.1:g.51554G>A
NG_009086.2:g.51572G>A
ENST00000409709.9:c.1997G>A
ENST00000409893.6:c.62G>A
ENST00000409619.6:c.1964G>A
ENST00000409709.7:c.1997G>A
ENST00000409893.5:c.1997G>A
ENST00000458637.6:c.1997G>A
ENST00000620575.4:c.1997G>A
NM_000260.3:c.1997G>A
NM_001127179.2:c.1997G>A
NM_001127180.1:c.1997G>A
NM_001127180.2:c.1997G>A
NM_001369365.1:c.1964G>A
More

Uncertain Significance

Met criteria codes 1
PP3
Not Met criteria codes 2
BS1 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Hearing Loss Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDH23, COCH, GJB2, KCNQ4, MYO6, MYO7A, SLC26A4, TECTA and USH2A Version 2

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The c.1997G>A variant in MYO7A is a missense variant predicted to cause substitution of arginine by glycine at amino acid 666. The highest population minor allele frequency in gnomAD v4.1 is 0.0001865 (14/75048 alleles) in the African/African-American population (PM2_Supporting and BS1_Supporting are not met). The computational predictor REVEL gives a score of 0.841, which is above the threshold of 0.7, evidence that correlates with impact to MYO7A function (PP3). This variant has been observed in one proband with Usher syndrome, four probands with hearing loss, and two probands with retinal disease. However, they all harbored another variant of uncertain significance c.3527G>A (p.Ser1176Asn) with phase unknown, and two who were found to have an alternate molecular basis for disease (PM3_Supporting not met; ClinVar ID: 196099; PMIDs: 27460420, 31479088, 33297549, 27344577, LabCorp Genetics (formerly Invitae) internal data ClinVar SCV001498602.2, GeneDx internal data). In summary, this variant has been classified as a variant of uncertain significance for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PP3 (ClinGen Hearing Loss VCEP specifications version 2; 3/12/2025).
Met criteria codes
PP3
The computational predictor REVEL gives a score of 0.841, which is above the threshold of 0.7, evidence that correlates with impact to MYO7A function (PM3 met)
Not Met criteria codes
BS1
The highest population minor allele frequency in gnomAD v4.1 is 0.0001865 (14/75048 alleles) in the African/African-American population (PM2_Supporting and BS1_Supporting are not met).
PM2
The highest population minor allele frequency in gnomAD v4.1 is 0.0001865 (14/75048 alleles) in the African/African-American population (PM2_Supporting and BS1_Supporting are not met).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.